Trial intelligence / Profile preview

Effects of Escitalopram vs. Duloxetine on Heart Rate Variability in Depression

NCT00215228Phase 3Completed

Sponsor
Duke University
Start
Jul 2005
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of duloxetine in major depressive disorder (MDD), sponsored by Duke University. Started Jul 2005; status: completed.

02

Drugs

duloxetine
03

Conditions

major depressive disorder (MDD)

Beyond the preview

Go deeper on NCT00215228.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00215228.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call